INMD
NASDAQInMode Ltd.
Website
News25/Ratings12
News · 26 weeks27-90%
2025-10-262026-04-19
Mix2290d
- Other8(36%)
- Insider7(32%)
- SEC Filings5(23%)
- Earnings2(9%)
Latest news
25 items- PRInMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375MConference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter of 2026 before the Nasdaq market opens on Wednesday, May 6, 2026. InMode is currently finalizing its financial results for the first quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of I
- PRInMode to Present at the 25th Annual Needham Virtual Healthcare ConferenceYOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026. The fireside chat, moderated by Michael Matson, Senior Equity Analyst, is scheduled for 11:00 am Eastern Time on Monday, April 13, and a live webcast of the presentation can be accessed here. InMode will also hold virtual one-on-one investor meetings
- INSIDERSEC Form 3 filed by InMode Ltd.3 - InMode Ltd. (0001742692) (Issuer)
- INSIDERSEC Form 3 filed by InMode Ltd.3 - InMode Ltd. (0001742692) (Issuer)
- INSIDERSEC Form 3 filed by new insider Mizrahy Moshe3 - InMode Ltd. (0001742692) (Issuer)
- INSIDERSEC Form 3 filed by new insider Kreindel Michael3 - InMode Ltd. (0001742692) (Issuer)
- INSIDERSEC Form 3 filed by InMode Ltd.3 - InMode Ltd. (0001742692) (Issuer)
- INSIDERSEC Form 3 filed by InMode Ltd.3 - InMode Ltd. (0001742692) (Issuer)
- INSIDERSEC Form 3 filed by InMode Ltd.3 - InMode Ltd. (0001742692) (Issuer)
- SECSEC Form 6-K filed by InMode Ltd.6-K - InMode Ltd. (0001742692) (Filer)
- PRInMode Announces New Share Repurchase ProgramYOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares. In 2025, the Company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the Company continues to generate strong cash fl
- PRInMode to Present at Upcoming Investor ConferencesYOKNEAM, Israel, Feb. 26, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March: Barclays 28th Annual Global Healthcare ConferencePresenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Matt Miksic, Senior Equity Analyst, and one-on-one meetingsLocation: Miami, FLWhen: Wednesday, March 11 at 12:30 pm ETA live webcast of the presentation can be accessed here.Oppenheimer 36th Annual Healthcare MedTech & Services ConferencePresenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial OfficerFormat: Virt
- SECSEC Form 6-K filed by InMode Ltd.6-K - InMode Ltd. (0001742692) (Filer)
- PRInMode Announces Conclusion of Independent Transaction Committee ReviewYOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent transaction committee of its Board of Directors (the "Committee") has completed its review of proposals received in connection with a potential transaction. Since its formation, the Committee has conducted a comprehensive and independent process to evaluate proposals received over the course of its work, with the assistance of external financial and legal advisors.Following a careful review of the final proposals received in connection with the potential transaction, the Committee has concluded
- SECSEC Form S-8 filed by InMode Ltd.S-8 - InMode Ltd. (0001742692) (Filer)
- SECSEC Form 20-F filed by InMode Ltd.20-F - InMode Ltd. (0001742692) (Filer)
- SECSEC Form 6-K filed by InMode Ltd.6-K - InMode Ltd. (0001742692) (Filer)
- PRInMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 MillionYOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Highlights: Quarterly GAAP revenues of $103.9 million, compared to $97.9 million in the fourth quarter of 2024.Quarterly revenues from consumables and service of $21.5 million, an increase of 8% compared to the fourth quarter of 2024.GAAP operation income of $26 million, *non-GAAP operation income of $28.5 million.Total cash position of $555.3 million as of December 31, 2025, including cash and cash equivalents, marketable securiti
- PRInMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools ConferenceYOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026. Interested investors are welcome to contact their BTIG salesperson and schedule a meeting. For more information about the event, visit InMode's investor relations site here. About InMode InMode is a leading global provider of innov
- SECSEC Form 6-K filed by InMode Ltd.6-K - InMode Ltd. (0001742692) (Filer)
- PRInMode Responds to Transaction RumorsYOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement: The Company is aware of recent market speculation and rumors, including reports relating to the publicly announced non-binding proposal by Steel Partners Holdings L.P. to acquire 51% of the Company's outstanding shares and recent statements attributed to the Company's Chief Executive Officer. Without derogating from the Company's general policy that it does not comment on market rumors, the Company wishes to inform investors that it is currently evaluating potential strategic alternatives. In
- PRSteel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd. to Board of DirectorsIssues Letter to Shareholders Detailing How Proposal Would Provide Superior Value and Pathway to Long-Term Participation in InMode's Future Success Proposed Per Share Purchase Price Represents 29% Premium to InMode's Unaffected Share Price Highlights Company's Dismal Total Shareholder Returns Over Past 1-, 3- and 5-Year Periods, Poor Capital Allocation Decisions and History of Persistently Cutting Guidance Steel Partners Holdings L.P. (together with its affiliates, "Steel"), which beneficially owns approximately 1.3% of the outstanding shares of InMode Ltd. (NASDAQ:INMD) ("InMode" or the "Company"), today issued a public letter to the Company's shareholders. The full text of the lette
- PRInMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8MConference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year of 2025 before the Nasdaq market opens on Tuesday, February 10, 2026. InMode is currently finalizing its financial results for the fourth quarter and full year of 2025. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode's financial results for such period, subject to final adjustments and ot
- PRInMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross MarginsYOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights: Quarterly GAAP revenues of $93.2 million, compared to $130.2 million in the third quarter of 2024, which included $31.9 million of pre-order sales.Quarterly revenues from consumables and service of $19.9 million, an increase of 26% compared to the third quarter of 2024.GAAP operating income of $20.9 million. *Non-GAAP operating income was $23.6 million.Total cash position of $532.3 million as of September 30, 2025, incl
- SECSEC Form 6-K filed by InMode Ltd.6-K - InMode Ltd. (0001742692) (Filer)